TAPI pump and dump

[anonymous]

Typical Teva - pump up the TAPI API prices on the generics they sell to try and make TAPI look like a good buy.

Delusional and desperate it’s Teva’s special skill.

 

[anonymous]

Viatris thought they’d get far more for their API business and their business was largely centred in low cost manufacturing sites, who really wants Teva sites in Israel, Europe and the Mexican shambles.

 

[anonymous]

Typical Teva - pump up the TAPI API prices on the generics they sell to try and make TAPI look like a good buy.

Delusional and desperate it’s Teva’s special skill.

Teva is incapable of any original strategy just copying Viatris playbook but with a heap more debt to pay down and way less R&D assets or family silver to sell.

 

[anonymous]

Batty boys

 

[anonymous]

I’m hearing that the TAPI sale is nowhere near as lucrative as expected.

 

[pillow]

is it in the US?

 

[anonymous]

I’m hearing that the TAPI sale is nowhere near as lucrative as expected.

Weren’t they after 2-3 billion?

 

[anonymous]

Weren’t they after 2-3 billion?

They might get 2-3 billion INR